SCHEMBL29324128

SCHEMBL29324128

CCCC(=O)OCSc1ccccc1C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.51
RAB9A P51151 4/20 0.48
POLB P06746 6/20 0.46
NPC1 O15118 3/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HSP90AA1 P07900 1/20 0.46
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA4 P22748 1/20 0.45
CA7 P43166 1/20 0.45
CA9 Q16790 1/20 0.45
ALDH1A1 P00352 3/20 0.45
RECQL P46063 2/20 0.44
KMT2A Q03164 2/20 0.44
KDM4E B2RXH2 1/20 0.44
MEN1 O00255 1/20 0.44
HSD17B10 Q99714 2/20 0.44
LMNA P02545 2/20 0.44
ICMT O60725 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16554644 0.79 HPGD (0.47) ALDH1A1KMT2AKDM4EMEN1HSD17B10
SCHEMBL6221028 0.78 CYP1A2 (0.61) CYP1A2RAB9APOLBNPC1SMN1; SMN2
Phthalic Acid SCHEMBL28439156 0.78 TSHR (0.53) SMN1; SMN2ALDH1A1RECQLKMT2AKDM4E
SCHEMBL6779779 0.76 CYP1A2 (0.62) CYP1A2RAB9APOLBNPC1SMN1; SMN2
SCHEMBL2747847 0.76 CYP1A2 (0.67) CYP1A2RAB9APOLBNPC1SMN1; SMN2
SCHEMBL4633858 0.75 CYP1A2 (0.61) CYP1A2RAB9APOLBNPC1SMN1; SMN2
SCHEMBL28728287 0.74 CYP1A2 (0.65) CYP1A2RAB9APOLBNPC1SMN1; SMN2
SCHEMBL27998062 0.74 CYP1A2 (0.65) CYP1A2RAB9APOLBNPC1SMN1; SMN2
Hydrochloric Acid SCHEMBL9952241 0.74 CYP1A2 (0.65) CYP1A2RAB9APOLBNPC1SMN1; SMN2
SCHEMBL11615588 0.74 TP53 (0.48) SMN1; SMN2ALDH1A1RECQLKMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4648770-A1 COMPOUNDS AND METHOD FOR TREATING HIV INFECTION The United States of America, as represented by the Secretary, Department of Health and Human Services (US) 2025-11-19 EP disclosed
WO-2024151425-A1 COMPOUNDS AND METHOD FOR TREATING HIV INFECTION THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2024-07-18 WO disclosed
WO-2024151425-A1 COMPOUNDS AND METHOD FOR TREATING HIV INFECTION THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2024-07-18 WO disclosed